What is Perspective Therapeutics Operating Cash Flow per Share?
Perspective Therapeutics's operating cash flow per share for the
three
months ended in Dec. 2023 was $-0.03.
Perspective Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.14.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -36.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.80% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Perspective Therapeutics's Operating Cash Flow per Share or its related term are showing as below:
CATX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -365.7 Med: 9.4 Max: 72.9
Current: -36.7
During the past 13 years, Perspective Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.90% per year. The lowest was -365.70% per year. And the median was 9.40% per year.
CATX's 3-Year OCF Growth Rate is ranked worse than 86.11% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs CATX: -36.70
Perspective Therapeutics Operating Cash Flow per Share Historical Data
The historical data trend for Perspective Therapeutics's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Perspective Therapeutics Operating Cash Flow per Share Chart
Competitive Comparison of Perspective Therapeutics's Operating Cash Flow per Share
For the Medical Devices subindustry, Perspective Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perspective Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Perspective Therapeutics's Price-to-Operating-Cash-Flow falls into.
Perspective Therapeutics Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Perspective Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perspective Therapeutics Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Perspective Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Perspective Therapeutics (Perspective Therapeutics) Business Description
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CATX has been successfully added to your 